CannaboTech
Botanical-based Medical Solutions
Company Overview
Snapshot
Founded in January 2019 by Moav Gafni and Yoav Rothler, CannaboTech operates with 1–10 employees. The company has raised $29 million across four funding rounds. In July 2021, CannaboTech went public on the TASE.
Business overview
CannaboTech develops advanced medical solutions for cancer, inflammation, and chronic pain, leveraging traditional botanical resources. The company's core technology utilizes cannabinoids and medicinal mushrooms to create its proprietary M²CBD formula. CannaboTech focuses on three classes of medical solutions: integrative care, preventive medicine, and botanical drugs, serving mainstream consumers seeking innovative and certified medical solutions within the Health Tech & Life Sciences sector.
Strategic signal
In March 2024, CannaboTech announced a significant deal to establish three concept stores for its preventive medicine brand in Thailand. This move signals a strategic expansion into the Southeast Asian market, indicating the company's focus on international growth and broadening the accessibility of its botanical-based medical solutions.
Log in to access full profile ›Company Intelligence Q&A
- When did CannaboTech go public?
- CannaboTech went public on the TASE in July 2021.
- What was a key finding from CannaboTech's research on colon cancer products?
- In March 2022, CannaboTech's "Integrative-Colon" products eliminated over 90% of colon cancer cells in a cell model experiment.
- What breakthrough did CannaboTech announce regarding its pancreatic cancer drug?
- In July 2022, CannaboTech announced a promising breakthrough in its pancreatic cancer drug, which showed a combined anti-cancer effect between cannabis and mushroom for the first time ever.
- What was the outcome of CannaboTech's research on its CannaboBreast products?
- In January 2022, research showed CannaboBreast products had a sixfold improvement in killing cancer cells.
- What recent international expansion has CannaboTech undertaken?
- In March 2024, CannaboTech signed an agreement to establish three concept stores for its preventive medicine brand in Thailand.